BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23253402)

  • 1. Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas.
    Schrader A; Meyer K; von Bonin F; Vockerodt M; Walther N; Hand E; Ulrich A; Matulewicz K; Lenze D; Hummel M; Kieser A; Engelke M; Trümper L; Kube D
    Cell Commun Signal; 2012 Dec; 10(1):43. PubMed ID: 23253402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF-R is expressed on B-cell lymphomas depending on their origin, and is related to proliferation index of nodal diffuse large B-cell lymphomas.
    Takahata H; Ohara N; Ichimura K; Tanaka T; Sato Y; Morito T; Takata K; Kojima M; Kobata T; Yoshino T
    J Clin Exp Hematop; 2010; 50(2):121-7. PubMed ID: 21123970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
    Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
    J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
    Phelan JD; Young RM; Webster DE; Roulland S; Wright GW; Kasbekar M; Shaffer AL; Ceribelli M; Wang JQ; Schmitz R; Nakagawa M; Bachy E; Huang DW; Ji Y; Chen L; Yang Y; Zhao H; Yu X; Xu W; Palisoc MM; Valadez RR; Davies-Hill T; Wilson WH; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Rodriguez FJ; Estephan F; Holdhoff M; Kruhlak MJ; Hewitt SM; Thomas CJ; Pittaluga S; Oellerich T; Staudt LM
    Nature; 2018 Aug; 560(7718):387-391. PubMed ID: 29925955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
    Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P38 mitogen activated protein kinase expression and regulation by interleukin-4 in human B cell non-Hodgkin lymphomas.
    Ding H; Gabali AM; Jenson SD; Lim MS; Elenitoba-Johnson KS
    J Hematop; 2009 Oct; 2(4):195-204. PubMed ID: 20309428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression data.
    Schrader A; Meyer K; Walther N; Stolz A; Feist M; Hand E; von Bonin F; Evers M; Kohler C; Shirneshan K; Vockerodt M; Klapper W; Szczepanowski M; Murray PG; Bastians H; Trümper L; Spang R; Kube D
    Oncotarget; 2016 Jul; 7(30):47061-47081. PubMed ID: 27166259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.
    Franco R; Scognamiglio G; Valentino E; Vitiello M; Luciano A; Palma G; Arra C; La Mantia E; Panico L; Tenneriello V; Pinto A; Frigeri F; Capobianco G; Botti G; Cerchia L; De Chiara A; Fedele M
    Oncotarget; 2016 Sep; 7(37):59158-59172. PubMed ID: 27494852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of transcription factors PAX5, OCT2, BCL6 and transcription regulator P53 in Non-Hodgkin lymphomas: A diagnostic cross-sectional study.
    Ismail S; Elshimali Y; Daoud A; Alshehabi Z
    Ann Med Surg (Lond); 2022 Jun; 78():103786. PubMed ID: 35600178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
    Tian X; Xu J; Dorfman DM
    Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging pathways in the development of AIDS-related lymphomas.
    Carbone A
    Lancet Oncol; 2003 Jan; 4(1):22-9. PubMed ID: 12517536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
    Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
    Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.
    Lu X; Nechushtan H; Ding F; Rosado MF; Singal R; Alizadeh AA; Lossos IS
    Blood; 2005 Apr; 105(7):2924-32. PubMed ID: 15591113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAFF, IL-4 and IL-21 separably program germinal center-like phenotype acquisition, BCL6 expression, proliferation and survival of CD40L-activated B cells in vitro.
    Robinson MJ; Pitt C; Brodie EJ; Valk AM; O'Donnell K; Nitschke L; Jones S; Tarlinton DM
    Immunol Cell Biol; 2019 Oct; 97(9):826-839. PubMed ID: 31276232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
    Swart JM; Bergeron DM; Chiles TC
    J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.